Landmark' data has revealed a popular weight loss medicine slashes the risk of heart attack, stroke or heart disease death ...

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events ...

For the first time, scientists have pitted the two most popular weight loss drugs against each other in a direct competition ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

Giving obese children weight-loss jabs is effective and helps prevent battles around mealtimes, researchers say. Experts at ...

Discover why Creative Medical Technology Holdings receives a Sell rating due to high risks, early-stage pipeline, and ...

Zaina Jasser urges patients and medical practitioners to be cautious of the moral and sociological implications of ...

Health and Human Services Secretary Robert F. Kennedy Jr. said that bringing the cost of prescription drugs to levels seen in ...

It found that people on GLP-1 drugs like Wegovy and Ozempic reported eating fewer processed foods, red meat and sugary drinks ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

Hims & Hers Health shows impressive operating leverage and a scalable business model, with massive growth potential from new ...